197 related articles for article (PubMed ID: 28814568)
21. Application of classification tree and neural network algorithms to the identification of serological liver marker profiles for the diagnosis of hepatocellular carcinoma.
Poon TC; Chan AT; Zee B; Ho SK; Mok TS; Leung TW; Johnson PJ
Oncology; 2001; 61(4):275-83. PubMed ID: 11721174
[TBL] [Abstract][Full Text] [Related]
22. Differential proteomic and tissue expression analyses identify valuable diagnostic biomarkers of hepatocellular differentiation and hepatoid adenocarcinomas.
Reis H; Padden J; Ahrens M; Pütter C; Bertram S; Pott LL; Reis AC; Weber F; Juntermanns B; Hoffmann AC; Eisenacher M; Schlaak JF; Canbay A; Meyer HE; Sitek B; Baba HA
Pathology; 2015 Oct; 47(6):543-50. PubMed ID: 26308133
[TBL] [Abstract][Full Text] [Related]
23. Case Report of an Hepatoid Adenocarcinoma of the Stomach.
Gaeta R; Ugolini C; Castagna M
Appl Immunohistochem Mol Morphol; 2016 Feb; 24(2):e6-8. PubMed ID: 26844385
[TBL] [Abstract][Full Text] [Related]
24. Alpha-fetoprotein (AFP)-producing gastric carcinoma. Is it hepatoid differentiation?
Ooi A; Nakanishi I; Sakamoto N; Tsukada Y; Takahashi Y; Minamoto T; Mai M
Cancer; 1990 Apr; 65(8):1741-7. PubMed ID: 1690592
[TBL] [Abstract][Full Text] [Related]
25. Integrated clinicopathological and immunohistochemical analysis of gastric adenocarcinoma with hepatoid differentiation: an exploration of histogenesis, molecular characteristics, and prognostic markers.
He F; Fu Y; Sun Q; Geng P; Zheng Z; Pu X; Shi J; Fan X
Hum Pathol; 2021 Sep; 115():37-46. PubMed ID: 33636206
[TBL] [Abstract][Full Text] [Related]
26. Clinical implications of alpha-fetoprotein expression in gastric adenocarcinoma.
Chen J; Röcken C; Treiber G; Jentsch-Ulrich K; Malfertheiner P; Ebert MP
Dig Dis; 2003; 21(4):357-62. PubMed ID: 14752227
[TBL] [Abstract][Full Text] [Related]
27. Hepatocellular oncofetal protein, glypican 3 is a sensitive marker for alpha-fetoprotein-producing gastric carcinoma.
Hishinuma M; Ohashi KI; Yamauchi N; Kashima T; Uozaki H; Ota S; Kodama T; Aburatani H; Fukayama M
Histopathology; 2006 Nov; 49(5):479-86. PubMed ID: 17064293
[TBL] [Abstract][Full Text] [Related]
28. BSEP and MDR3: Useful Immunohistochemical Markers to Discriminate Hepatocellular Carcinomas From Intrahepatic Cholangiocarcinomas and Hepatoid Carcinomas.
Fujikura K; Yamasaki T; Otani K; Kanzawa M; Fukumoto T; Ku Y; Hirose T; Itoh T; Zen Y
Am J Surg Pathol; 2016 May; 40(5):689-96. PubMed ID: 26735860
[TBL] [Abstract][Full Text] [Related]
29. Alpha-Fetoprotein-Producing Early Gastric Cancer with Intramucosal Hepatoid and Fetal Enteric Differentiation.
Iwaya M; Riddell R; Asano K; Kobayashi K; Uehara T; Ota H
Case Rep Gastroenterol; 2020; 14(2):426-435. PubMed ID: 32999644
[TBL] [Abstract][Full Text] [Related]
30. Fetal gut-like differentiation in gallbladder cancer.
Koyama K; Maeda D; Tamura D; Narita C; Kudo-Asabe Y; Sato T; Yamamoto Y; Sageshima M; Nanjo H; Goto A
Hum Pathol; 2017 Dec; 70():27-34. PubMed ID: 28970139
[TBL] [Abstract][Full Text] [Related]
31. Hepatoid gastric adenocarcinoma. A histological and immunohistochemical study of a case.
Caruso RA
Eur J Basic Appl Histochem; 1991; 35(2):203-9. PubMed ID: 1722709
[TBL] [Abstract][Full Text] [Related]
32. Hepatoid adenocarcinoma of the stomach: a case report.
Sugawara Y; Konishi T; Hiraishi M; Sato A; Natomi H; Aoki T; Makuuchi M
Hepatogastroenterology; 1996; 43(10):995-9. PubMed ID: 8884327
[TBL] [Abstract][Full Text] [Related]
33. Hepatoid adenocarcinoma of the urinary bladder.
Lopez-Beltran A; Luque RJ; Quintero A; Requena MJ; Montironi R
Virchows Arch; 2003 Apr; 442(4):381-7. PubMed ID: 12715173
[TBL] [Abstract][Full Text] [Related]
34. [Expression of glypican-3, hepatocyte antigen, alpha-fetoprotein, CD34 and CD10 in hepatocellular carcinoma: a clinicopathologic analysis of 375 cases].
Du JL; Wang YL; Shi HY; Guo AT; Wei LX
Zhonghua Bing Li Xue Za Zhi; 2012 May; 41(5):309-13. PubMed ID: 22883669
[TBL] [Abstract][Full Text] [Related]
35. Hepatoid tumors of the gastrointestinal/pancreatobiliary district: morphology, immunohistochemistry, and molecular profiles.
Mattiolo P; Scarpa A; Luchini C
Hum Pathol; 2023 Feb; 132():169-175. PubMed ID: 35714834
[TBL] [Abstract][Full Text] [Related]
36. Hepatoid adenocarcinoma of the lung: Review of a rare form of lung cancer.
Grossman K; Beasley MB; Braman SS
Respir Med; 2016 Oct; 119():175-179. PubMed ID: 27692141
[TBL] [Abstract][Full Text] [Related]
37. Hepatoid adenocarcinoma of the gallbladder: a mimicker of hepatocellular carcinoma.
van den Bos IC; Hussain SM; Dwarkasing RS; Stoop H; Zondervan PE; Krestin GP; de Man RA
Br J Radiol; 2007 Dec; 80(960):e317-20. PubMed ID: 18065642
[TBL] [Abstract][Full Text] [Related]
38. alpha-Fetoprotein-producing liver carcinomas of primary extrahepatic origin.
Wee A; Thamboo TP; Thomas A
Acta Cytol; 2003; 47(5):799-808. PubMed ID: 14526683
[TBL] [Abstract][Full Text] [Related]
39. Both the serum AFP test and AFP/GPC3/SALL4 immunohistochemistry are beneficial for predicting the prognosis of gastric adenocarcinoma.
Wang B; Xie Y; Zheng L; Zheng X; Gao J; Liu X; Yuan Y; Li Z; Lu N; Xue L
BMC Gastroenterol; 2021 Oct; 21(1):408. PubMed ID: 34706681
[TBL] [Abstract][Full Text] [Related]
40. Applicability of BALAD score in prognostication of hepatitis B-related hepatocellular carcinoma.
Chan SL; Mo F; Johnson P; Li L; Tang N; Loong H; Chan AW; Koh J; Chan AT; Yeo W
J Gastroenterol Hepatol; 2015 Oct; 30(10):1529-35. PubMed ID: 25968302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
